Investors
Events & Presentations
Financial & Filings
Stock Information
Investor FAQs
Contact Us
Newsroom
Areas of Focus
Cardiometabolic
Severe Hypertriglyceridemia
Dyslipidemia
Cardiovascular Disease
Obesity
Pulmonary
Inflammatory Pulmonary Diseases
Idiopathic Pulmonary Fibrosis
Pipeline
Science & Innovation
Partnerships
Publications
Clinical Trials
Patients & Caregivers
What is RNAi?
Expanded Access Programs
FCS Patient Insights
About
Leadership Team
Corporate Governance
Careers
Job Openings
Investors
Events & Presentations
Financial & Filings
Stock Information
Investor FAQs
Contact Us
Newsroom
GSK enters agreement to obtain exclusive license for JNJ-3989 to expand the development of bepirovirsen
Home
/
Newsroom
/
GSK enters agreement to obtain...
